en

PRODUCT DETAIL

Praluent 300 mg injekčný roztok v naplnenom injekčnom pere

Code 9343E
MA number EU/1/15/1031/021
Product Form: sol inj 1x2 ml/300 mg (pero napl. bez aktiv.tlačidla)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Sanofi Winthrop Industrie, France
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10A Lipid modifying agents, plain
C10AX Other lipid modifying agents
C10AX14 Alirocumab
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 23.09.2015
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 23.03.2025
eu-flag.png sk-flag.png